Beating liver cancer in Europe – the empowerment of prevention and early detection
Under the patronage of the Slovenian presidency of the Council of the European Union, the European Association for Study of the Liver (EASL) and the European Liver Patients’ Association (ELPA) are organising an advocacy event with the support of: University…
EASL NAFLD Summit 2022
NAFLD is the leading cause of chronic liver disease, along with higher risk of diabetes, cardiovascular disease, and cancer, and thus a major public health challenge. NAFLD represents a therapeutic area of as yet unmet clinical lead. This 4th iteration…
COVID-19 Webcast series
This episode of EASL’s webcast series on COVID-19 and the liver examines the impact of the virus on patients with obesity and fatty liver disease. The panel of experts comprises Professor Sven Francque, Professor Nalu Navarro-Alvarez, Professor Luca Busetto and…